Posts Tagged ‘Financial Stocks’

CPBM flies, ELCR accelerates, NTFL bruised

Thursday, January 13th, 2011

Cyplasin Biomedical Ltd. (OTCBB: CPBM) doubled in price Thursday to eight cents, on volume of 556,350 shares, at least 10 times its daily average. Through its wholly-owned subsidiary, Astro Nutrition Inc., CPBM functions as a reseller of health products and herbal remedies.

Electric Car Company Inc. (OTCBB: ELCR) was busy Thursday, trading in 98.9 million shares, compared to a daily average of 75.2 million. The price doubled Thursday to two-100ths of a cent.

Network 1 Financial Group Inc. (OTCBB: NTFL) stumbled 61 percent in price Thursday to 3.9 cents. Volume was 44,960 shares trounced its normal daily average. The company generates income from transactional business, mutual fund sales, business consulting fees, finder’s fees, and annuity sales.

EXFO excels, C steady, LEDS falls

Thursday, January 13th, 2011

Exfo Inc. (Nasdaq: EXFO) shares gained 21.7 percent to $9.21 Thursday. Volume was 1,068,654, leaps and bounds better than its full-day volume average of 34,688, after the Canadian telecom-testing-equipment maker reported first-quarter earnings that exceeded its own forecast.

Citigroup (NYSE: C) traded in 179,303,239 shares Thursday, about a third its daily average of 547,887,000. Prices for C were flat at $5.07.

SemiLEDS Corporation (Nasdaq: LEDS) fell 33 percent Thursday to $19.17 Volume for the stock was 4,007,597 shares, eight times its full-day average. The company said new pricing pressures will lead to slimmer profit and revenue for the newly-public company over the next three months.

BRN gains momentum, MSFT has good volume, FRBK loses air

Wednesday, January 12th, 2011

Barnwell Industries Inc. (AMEX: BRN) shares gained 23.6% to $7.50 Wednesday. Volume of 183,617 shares dwarfed its full-day average of 9,411. Barnwell engages in oil and natural gas exploration, development, production and sales in Canada.

Microsoft Inc. (Nasdaq: MSFT) traded in 42,033,218 shares Wednesday, approaching its daily average of 57,414,000. Prices for MSFT nudged ahead 1.2 percent to $28.45.

Republic First Bancorp. (Nasdaq: FRBK) fell 8 percent Wednesday to $2.75 Volume for the stock was 132,273 shares, or about 2 1/2 its daily average. FRBK is a full-service, state-chartered commercial bank with offices and branches throughout Pennsylvania and New Jersey.

ITT is it, GE active, CPF falters

Wednesday, January 12th, 2011

ITT Corp. (NYSE: ITT) shares gained 13.9% to $60.10 Wednesday after the defense contractor said it would split into three separate publicly traded companies. Volume of 14,510,255 overwhelmed a full-day average of 1,262,170.

General Electric Company (NYSE: GE) traded in 31,018,867 shares Wednesday, just better than half its all-day average of 57,041,400. Prices for GE were flat at $18.64. Wednesday, GE Intelligent Platforms announced the PCIE-5565PIORC low profile PCI Express reflective memory node card

Central Pacific Financial Corp. (NYSE: CPF) fell 8.2 percent Wednesday to $2.25. Volume for the stock was 924,167 shares or nearly 4 1/2 times its daily average, only a day after double-digit stock gains.

SDIX soars, BAC busy, KV troubled

Wednesday, January 12th, 2011

Strategic Diagnostics Inc. (Nasdaq: SDIX) shares shot higher 42.5 percent Wednesday to $2.65, on volume of 2,094,668 shares, towering over its full-day average of about 31,000. SDIX announced Wednesday its RapidChek SELECT Salmonella Enteritidis (SE) test system has been reviewed by FDA and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.

Bank of America Corp. (NYSE: BAC) traded in 113,699,846 shares noon Wednesday, nearly half its all-day average. Prices for BAC moved forward 1.8 percent to $14.95, as part of a general upward trend for bank stocks.

K-V Pharmaceutical Company (NYSE: KV.A) fell 21.9 percent Wednesday to $1.78. Volume for the stock was 1,722,746 shares or nearly five times its daily verage, after the company said it was “evaluating its liquidity outlook” in light of a delay by U.S. regulators over approval of a treatment to prevent preterm birth.